GAMZU ELKAN R 4
4 · PHARMOS CORP · Filed Dec 2, 2004
Insider Transaction Report
Form 4
PHARMOS CORPPARS
GAMZU ELKAN R
Director
Transactions
- Exercise/Conversion
Common Stock
2004-12-01$1.02/sh+1,250$1,275→ 1,250 total - Sale
Common Stock
2004-12-01$3.95/sh−2,500$9,875→ 0 total - Exercise/Conversion
Stock Options
2004-12-01−1,250→ 10,250 totalExercise: $1.02From: 2004-11-17Exp: 2013-02-17→ Common Stock (1,250 underlying)
Footnotes (2)
- [F1]Sale is pursuant to a 10b5-1 trading plan previously established by Dr. Gamzu.
- [F2]The remaining 10,250 options become exercisable in nine equal quarterly installments beginning 2-17-05.